<DOC>
	<DOC>NCT00740649</DOC>
	<brief_summary>This is a single ascending dose study of HSD-016 to provide the initial assessment of the safety, tolerability, how the drug is absorbed and eliminated, and it's effect on the body in Japanese male subjects.</brief_summary>
	<brief_title>Single Ascending Dose Study of the Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of HSD-016</brief_title>
	<detailed_description />
	<criteria>Inclusion: 1. Men, aged 20 to 45 years inclusive at screening. 2. Body mass index (BMI) in the range of 17.6 to 26.4 kg/m2 and body weight â‰¥45 kg 3. Healthy as determined by the investigator on the basis of screening evaluations. 4. Nonsmoker or smoker of fewer than 10 cigarettes per day as determined by history. Exclusion: 1. No presence or history of any disorder that may prevent the successful completion of the study. 2. No history of drug abuse within 1 year.</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>March 2009</verification_date>
</DOC>